arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MEDICINOVA INC

MNOV
$1.45 ▼ -0.01 (-0.68%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
26 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDICINOVA INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $71.1M
Dividend Yield —
Revenue Growth —
Op. Margin None
ROIC -32.0% ↘
FCF / Share $-0.20 ↗
Trailing P/E —
Price / Book 1.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

26-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$409.66K
↓ -59.0% —
Net Income Profit after all expenses
$-12.00M
↓ -8.6% —
FCF / Share Free cash flow per share
$-0.20
↑ +7.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
24
Cash Quality ↓
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 26 years · 78 quarters